AstraZeneca Nolvadex Patent Valid Until 2002, Firm Says After Court Ruling
Executive Summary
AstraZeneca expects that generic competition to Nolvadex will be limited to Barr's "authorized" tamoxifen until Aug. 20, 2002, following a Boston federal court ruling against Teva/Pharmachemie.